0001140361-15-024197.txt : 20150612 0001140361-15-024197.hdr.sgml : 20150612 20150612182946 ACCESSION NUMBER: 0001140361-15-024197 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150610 FILED AS OF DATE: 20150612 DATE AS OF CHANGE: 20150612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARDELYX, INC. CENTRAL INDEX KEY: 0001437402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34175 ARDENWOOD BLVD. CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 510-745-7047 MAIL ADDRESS: STREET 1: 34175 ARDENWOOD BLVD. CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: NTERYX INC DATE OF NAME CHANGE: 20080611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RINGOLD GORDON CENTRAL INDEX KEY: 0001101713 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36485 FILM NUMBER: 15929692 MAIL ADDRESS: STREET 1: 325 EAST MIDDLEFIELD AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4 1 doc1.xml FORM 4 X0306 4 2015-06-10 0 0001437402 ARDELYX, INC. ARDX 0001101713 RINGOLD GORDON C/O ARDELYX, INC. 34175 ARDENWOOD BLVD, SUITE 100 FREMONT CA 94555 1 0 0 0 Common Stock 2015-06-10 4 P 0 10000 15.1880 A 10000 I By IRA Stock Option (Right to Buy) 14.60 2015-06-11 4 A 0 15000 0.00 A 2025-06-11 Common Stock 15000 15000 D This transaction was executed in multiple trades in prices ranging from $14.915 to $15.43, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. /s/ Elizabeth Grammer, Attorney-in-Fact for Gordon Ringold 2015-06-12